title: Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension.
abstract: Although elevated renin-angiotensin system activity and angiotensinergic signaling within the brain are required for hypertension, polydipsia, and increased metabolic rate induced by deoxycorticosterone acetate (DOCA)-salt, the contribution of specific receptor subtypes and brain nuclei mediating these responses remains poorly defined. We hypothesized that angiotensin type 1a receptors (AT(1a)R) within the subfornical organ (SFO) mediate these responses. Transgenic mice carrying a conditional allele of the endogenous AT(1a)R (AT(1a)R(flox)) were administered an adenovirus encoding Cre-recombinase and enhanced green fluorescent protein (eGFP) or adenovirus encoding eGFP alone into the lateral cerebral ventricle. Adenovirus encoding Cre-recombinase reduced AT(1a)R mRNA and induced recombination in AT(1a)R(flox) genomic DNA specifically in the SFO, without significant effect in the paraventricular or arcuate nuclei, and also induced SFO-specific recombination in ROSA(TdTomato) reporter mice. The effect of SFO-targeted ablation of endogenous AT(1a)R was evaluated in AT(1a)R(flox) mice at 3 time points: (1) baseline, (2) 1 week after virus injection but before DOCA-salt, and (3) after 3 weeks of DOCA-salt. DOCA-salt-treated mice with deletion of AT(1a)R in SFO exhibited a blunted increase in arterial pressure. Increased sympathetic cardiac modulation and urine copeptin, a marker of vasopressin release, were both significantly reduced in DOCA-salt mice when AT(1a)R was deleted in the SFO. Additionally, deletion of AT(1a)R in the SFO significantly attenuated the polydipsia, polyuria, and sodium intake in response to DOCA-salt. Together, these data highlight the contribution of AT(1a)R in the SFO to arterial pressure regulation potentially through changes on sympathetic cardiac modulation, vasopressin release, and hydromineral balance in the DOCA-salt model of hypertension.
authors.affiliation: Department of Pharmacology, University of Iowa, Iowa City, IA 52242, USA.
authors.forename: Aline M
authors.initials: AM
authors.lastname: Hilzendeger
authors.forename: Martin D
authors.initials: MD
authors.lastname: Cassell
authors.forename: Deborah R
authors.initials: DR
authors.lastname: Davis
authors.forename: Harald M
authors.initials: HM
authors.lastname: Stauss
authors.forename: Allyn L
authors.initials: AL
authors.lastname: Mark
authors.forename: Justin L
authors.initials: JL
authors.lastname: Grobe
authors.forename: Curt D
authors.initials: CD
authors.lastname: Sigmund
mesh_terms: D000818:Animals; D062186:Arterial Pressure / Q000187:drug effects; D015415:Biomarkers / Q000652:urine; D003900:Desoxycorticosterone / Q000009:adverse effects*; D006020:Glycopeptides / Q000652:urine; D006321:Heart / Q000187:drug effects / Q000294:innervation; D006973:Hypertension / Q000139:chemically induced*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008901:Mineralocorticoids / Q000009:adverse effects*; D059606:Polydipsia / Q000139:chemically induced; D011141:Polyuria / Q000139:chemically induced; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics / Q000502:physiology*; D011995:Recombination, Genetic; D012964:Sodium / Q000378:metabolism; D013356:Subfornical Organ / Q000187:drug effects* / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000187:drug effects
chemical_list: D015415:Biomarkers; D006020:Glycopeptides; D008901:Mineralocorticoids; D044140:Receptor, Angiotensin, Type 1; C048197:copeptins; D003900:Desoxycorticosterone; D012964:Sodium